speb/financial-data huggingface dataset:
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 482400000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 3645400000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4403500000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1112700000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 4419900000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -482400000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -84189082.13
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 636200000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 16404500000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -482400000.00
MAXHEALTH.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -482400000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — +Operating Expense: 45581800000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 12199400000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — +Total Revenue: 82254300000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 21428900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 8590400000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8590400000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 9697500000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 9697500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -17952700000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -17952700000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 52382000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 52382000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -673000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -673000000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Amortization: 508500000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 508500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 54600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 54600000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 972215909.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 3.52
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 6615800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 28491100000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 28491100000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -14845300000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 5715400000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5715400000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 9731300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 9731300000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 6658000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6658000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6684300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6684300000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -1456200000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 5740700000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 5740700000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 917300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 917300000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -87300000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -368400000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 41700000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Change In Payable: 732900000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -3231200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -2626800000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 36000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Common Stock: 9731300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 9731300000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 107466300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 107466300000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 338200000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 6937000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 6937000000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 17899100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4395400000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Current Assets: 19447900000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 19447900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 322200000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 322200000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Current Debt: 4681600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 4681600000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 5003800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5003800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 1000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 1000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 21869400000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 21869400000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 154800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 154800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Defined Pension Benefit: 200000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Depreciation: 3956800000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4465300000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4465300000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1230200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 3956800000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1230200000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 977771429.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.50
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 14424100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 3422200000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 5400000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 5400000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — EBIT: 18906200000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — EBIT: 5312400000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — EBITDA: 23371500000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — EBITDA: 6542600000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 6200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — End Cash Position: 6658000000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 592700000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1487900000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -6500000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 20762700000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4729000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Goodwill: 34882400000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 34882400000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 60072500000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 60072500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 10370500000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 10370500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 94689300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 94689300000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Gross Profit: 64355200000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 17033500000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Interest Expense: 2150400000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 666600000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 2150400000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 666600000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Interest Income: 1150400000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Interest Income: 321500000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 1150400000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 321500000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -2267700000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 1187500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Inventory: 1142800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1142800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 136534500000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 136534500000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -16889900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 46600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 46600000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 54600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 54600000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 338200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 5392900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 22957600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 22957600000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 5393200000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5393200000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 24386600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 24386600000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 29779800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 29779800000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 5392900000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1438100000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 1278200000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 1278200000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 12333900000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 12333900000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 406600000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 338200000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Net Debt: 22410200000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 22410200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 26600000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Income: 14424100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Income: 3422200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 14424100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 3422200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 14424100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3422200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 14424100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3422200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 14424100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3422200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 16755800000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 14424100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3422200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1200600000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -345100000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -25700000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 4239300000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 3954800000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1200600000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -345100000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -143500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Net PPE: 76736600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 76736600000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -14684800000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 284500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 47393800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 47393800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 2354700000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 2354700000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 464900000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 464900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6875300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6875300000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 3732700000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 3732700000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 24263800000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 6542600000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Normalized Income: 15192229509.18
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 3422200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 16333200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Operating Income: 18773400000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Operating Income: 4834100000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Operating Revenue: 82254300000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 21428900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 973135041.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 973135041.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 547900000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 547900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 18000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 18000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 1467800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1467800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 25190100000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 25190100000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 795100000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 3565300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3565300000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 2681400000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2681400000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 101900000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 156800000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 6651900000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2837500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Payable: 4145000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 4145000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Properties: 23969700000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 23969700000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 709700000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 709700000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 26300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 26300000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Other Special Charges: 328200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Payables: 12740800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Payables: 12740800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 683000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 683000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 517600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 517600000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Pretax Income: 16755800000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 4645800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -312200000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -38500000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -14845300000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 17899100000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4395400000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 4465300000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1230200000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 374900000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 374900000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1438100000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 348000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 348000000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 92500000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 43961500000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 43961500000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 406600000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 12800000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 160500000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 1194300000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 21957000000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 4729000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Share Issued: 973135041.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 973135041.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 284500000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Special Income Charges: -892300000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 483300000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 107466300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 107466300000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 47393800000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 47393800000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -124170490.82
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Tax Provision: 2331700000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 1223600000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.14
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 348000000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 348000000.00
MAXHEALTH.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -3719000000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Total Assets: 172309400000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 172309400000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 131852900000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 131852900000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Total Debt: 34783600000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 34783600000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 107466300000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 107466300000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Total Expenses: 63480900000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 16594800000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 64843100000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 64843100000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 152861500000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 152861500000.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 42973700000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 42973700000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 200600000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -892300000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -892300000.00
MAXHEALTH.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MAXHEALTH.NS balance_sheet (annual, 2026-03-31) — Working Capital: -2421500000.00
MAXHEALTH.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: -2421500000.00
MAXHEALTH.NS income_statement (annual, 2026-03-31) — Write Off: 471600000.00
MAXIND.NS income_statement (annual, 2022-03-31) — +Operating Expense: 1068719000.00
MAXIND.NS income_statement (annual, 2022-03-31) — +Total Revenue: 1881264000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 95122000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 57099000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -687919000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 51135000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -33000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Amortization: 1083000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1000000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 78000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 56941827.00
MAXIND.NS income_statement (annual, 2022-03-31) — Basic EPS: -2.83
MAXIND.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 237257000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1089567000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -30204000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Capital Expenditure Reported: -36793000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 203997000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 537863000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 137823000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 3986504000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 53363000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 84460000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Change In Inventory: 1190120000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 35624000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: -201827000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Change In Payable: -196746000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Change In Receivables: 22356000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 805793000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -99435000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Common Stock: 537863000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 6413711000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Common Stock Payments: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 2194000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 1290413000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Current Assets: 5491705000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 24464000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Current Debt: 13821000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 38285000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 206000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 1531862000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 7000000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Depreciation: 69854000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 70854000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 70937000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 69854000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 57142975.00
MAXIND.NS income_statement (annual, 2022-03-31) — Diluted EPS: -2.83
MAXIND.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -161357000.00
MAXIND.NS income_statement (annual, 2022-03-31) — EBIT: -87835000.00
MAXIND.NS income_statement (annual, 2022-03-31) — EBITDA: -16898000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — End Cash Position: 137823000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -939414000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 1285454000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 634754000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -81048000.00
MAXIND.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 148888000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Goodwill: 1213000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 3743000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 57132000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 1585513000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Gross Profit: 590851000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Interest Expense: 92452000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 92452000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Interest Income: 30997000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 30997000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -69336000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 171125000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Inventory: 1303560000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 6817342000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: 175021000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 693001000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 78000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 199328000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 192377000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 179533000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 389810000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 569343000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -817905000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 199328000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 65300000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 301375000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Minority Interests: 0.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -2895000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Net Debt: 265808000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Income: -161357000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -161357000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -161357000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -161357000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -161357000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -128987000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -161357000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Interest Income: -71822000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Investment Properties Purchase And Sale: -36793000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 463034000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -817905000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -817905000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -71822000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 21857000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Net PPE: 897594000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -27953000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -20382000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 6409968000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 12765000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 65278000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 616814000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: -371031000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Normalized Income: -478306300.18
MAXIND.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 664958000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Operating Income: -477868000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Operating Revenue: 1881264000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 56942103.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 97600000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 34864000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 13475000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 2530000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: -77395000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 605300000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 33731000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 134673000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Payable: 37620000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Properties: 852700000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 26696000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 3848681000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Other Special Charges: -408799000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Payables: 132742000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6790000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 117846000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Pretax Income: -180287000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: -2895000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -2756489000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment Properties: -36793000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -30204000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 18106000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 1290413000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 70854000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 20509000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 20509000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -817905000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: 0.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 0.00
MAXIND.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 51300000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -166446000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 3219523000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 2251000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 62229000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 211117000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Share Issued: 56942103.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -20382000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Special Income Charges: 348777000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Stock Based Compensation: 13475000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 6413711000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 6409968000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 37183699.82
MAXIND.NS income_statement (annual, 2022-03-31) — Tax Provision: -18930000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.10
MAXIND.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 28500000.00
MAXIND.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: 43807000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Assets: 8583177000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 6803521000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Debt: 607628000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 6413711000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Total Expenses: 2359132000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 2169466000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 3091473000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 637604000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 10367000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
MAXIND.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 354133000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 354133000.00
MAXIND.NS balance_sheet (annual, 2022-03-31) — Working Capital: 3959843000.00
MAXIND.NS income_statement (annual, 2022-03-31) — Write Off: 8722000.00
MAXIND.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1092594000.00
MAXIND.NS income_statement (annual, 2023-03-31) — +Total Revenue: 2010334000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 109015000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 28565000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -741668000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 51135000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -827000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Amortization: 936000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 902000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1400000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 50358993.00
MAXIND.NS income_statement (annual, 2023-03-31) — Basic EPS: -2.06
MAXIND.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 137823000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1131071000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -36631000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 228819000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 430290000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 887266000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 3856368000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 802600000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 84666000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 793449000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -26589000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 21726000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Change In Payable: 38080000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 28534000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 864345000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 749443000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Common Stock: 430290000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 5421052000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Common Stock Payments: -914367000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 2194000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 914209000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4591333000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 43524000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Current Debt: 762000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 44286000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 338000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1614404000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 3200000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Depreciation: 83551000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 84453000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 84487000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 83551000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 50550613.00
MAXIND.NS income_statement (annual, 2023-03-31) — Diluted EPS: -2.06
MAXIND.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -103829000.00
MAXIND.NS income_statement (annual, 2023-03-31) — EBIT: 32044000.00
MAXIND.NS income_statement (annual, 2023-03-31) — EBITDA: 116531000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — End Cash Position: 887266000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -1185359000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 493032000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 657520000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -60023000.00
MAXIND.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 172430000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Goodwill: 1213000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 3697000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 29392000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 1650495000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Gross Profit: 1096125000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Interest Expense: 62131000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 62131000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Interest Income: 87253000.00
MAXIND.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 87253000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -36628000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 195885000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Inventory: 510111000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 5645184000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 1240651000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 681541000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1400000.00
MAXIND.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 186691000.00
MAXIND.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00